Correlating Circulating Vitamin D3 with Aspects of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Healthy Female Volunteers

References

• Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med. 2006;12(1):75–80. doi:10.1038/nm0106-75.
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356–9. doi:10.1001/jama.287.3.356.
   PubMed Web of Science ®Google Scholar
• Emery N. The global diabetes epidemic brought to you by global development. The Atlantic, July 2, 2012. [accessed 2020 Feb 2]. www.theatlantic.com/health/…/07/…diabetes-epidemic…/259305/.
   Google Scholar
• Dreisbach AW, Batuman V. Epidemiology of hypertension (Updated Dec 29, 2014). [accessed 2020 Feb 2]. http://emedicine.medscape.com/article/1928048-overview#aw2aab6b3.
   Google Scholar
• Preuss HG, Clouatre D. Potential of diet and dietary supplementation to ameliorate the chronic clinical perturbations of the metabolic syndrome. In: Sinatra S, Houston M, editors. Nutritional and integrative strategies in cardiovascular medicine. (eds), Boca Raton, FL: CRC Press; 2015. p. 148–78..
   Google Scholar
• Preuss HG, Preuss JM. The global diabetes epidemic: focus on the role of dietary sugars and refined carbohydrates in strategizing prevention. In: Rothkopf MM, Nusbaum MJ, and Haverstick LP, editors. Metabolic medicine and surgery. Boca Raton FL: CRC Press; 2014. p. 183–206.
   Google Scholar
• George PS, Pearson ER, Witham MD. Effect of Vitamin D3 supplementation on glycemic control and insulin resistance: a systemic review and meta-analysis. Diabet Med. 2012;29:142–50.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–29. doi:10.1210/jc.2007-0298.
   PubMed Web of Science ®Google Scholar
• Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57(10):2619–25. doi:10.2337/db08-0593.
   PubMed Web of Science ®Google Scholar
• Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820–5. doi:10.1093/ajcn/79.5.820.
   PubMed Web of Science ®Google Scholar
• Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89(5):552–72. doi:10.1079/BJN2003837.
   PubMed Web of Science ®Google Scholar
• Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267(3 Pt 1):E356–360. doi:10.1152/ajpendo.1994.267.3.E356.
   PubMedGoogle Scholar
• Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia . 1986;29(3):142–5. doi:10.1007/BF02427083.
   PubMed Web of Science ®Google Scholar
• Ju SY, Jeong HS, Kim DH. Blood vitamin D3 status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab. 2014;99(3):1053–63. doi:10.1210/jc.2013-3577.
   PubMed Web of Science ®Google Scholar
• Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28(5):1228–30. doi:10.2337/diacare.28.5.1228.
   PubMed Web of Science ®Google Scholar
• Dimova R, Tankova T, Chakarova N. Vitamin D3 in the spectrum of prediabetes and cardiovascular autonomic dysfunction. J Nutr. 2017;147:1607–15.
   PubMed Web of Science ®Google Scholar
• Kharb S, Goel K. Role of vitamin D3 in prediabetes. Annals of Diabetes Res. 2018;2(1):1008.
   Google Scholar
• Lagunova Z, Porojnicu AC, Lindberg FA, Aksnes L, Moan J. Vitamin D3 status in Norwegian children and adolescent with excess body weight. Pediatr Diabetes. 2011;12(2):120–6. doi:10.1111/j.1399-5448.2010.00672.x.
   PubMed Web of Science ®Google Scholar
• Chen L-W, Chien C-H, Kuo S-F, Yu C-Y, Lin C-L, Chien R-N. Low Vit D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty live disease: a community-based study. BMC Gastroenterol. 2019;19(1):126. doi:10.1186/s12876-019-1040-y.
   PubMedGoogle Scholar
• Barchetta I, Angelico F, Ben DM, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between non-alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D3 levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9(1):85. http://www.biomedcentral.com/1741-7015/9/85 doi:10.1186/1741-7015-9-85.
   PubMedGoogle Scholar
• Liangpunsakul S, Chalasani N. Serum vitamin D3 concentrations and unexplained elevation in ALT among US adults. Dig Dis Sci. 2011;56(7):2124–9. doi:10.1007/s10620-011-1707-x.
   PubMed Web of Science ®Google Scholar
• Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, Koteish AA, Clark JM, Guallar E, Hernaez R. Meta-analysis: Vitamin D and non-alcoholic fatty liver disease . Aliment Pharmacol Ther. 2013;38(3):246–54. doi:10.1111/apt.12377.
   PubMed Web of Science ®Google Scholar
• Eliades M, Spyrou E. Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol. 2015;21(6):1718–27. doi:10.3748/wjg.v21.i6.1718.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Kaats GR, Mrvichin N, Swaroop A, Bagchi D, Clouatre D, Preuss JM. Examining the relationship between nonalcoholic fatty liver disease and the metabolic syndrome in nondiabetic subjects. J Am Coll Nutr. 2018;37(6):457–65. doi:10.1080/07315724.2018.1443292.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Kaats GR, Mrvichin N, Bagchi D, Preuss JM. Circulating ALT and AST levels in relatively healthy volunteers over lifespan: assessing aging paradox and nutritional implications. J Am Coll Nutr. 2019;38(8):661–9. doi:10.1080/07315724.2019.1580169.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Mrvichin N, Bagchi D, Preuss J, Perricone N, Kaats GR. Importance of fasting blood glucose in screening/tracking over-all health. The Original Internist. 2016;23:13–20.
   Google Scholar
• Preuss HG, Mrvichin N, Bagchi D, Preuss J, Perricone N, Kaats GR. Fasting circulating glucose levels in the non-diabetic range correlate appropriately with many components of the metabolic syndrome. Original Internist. 2016;23:78–89.
   Google Scholar
• Preuss HG. Insulin resistance syndrome: a crucial example where a physiological continuum of risks needs attention. In: Bagchi D, Nair S, editors. Nutritional and therapeutic interventions for diabetes and metabolic syndrome. 2nd edition. London, UK: Academic Press; 2018. p. 227–34.
   Google Scholar
• Preuss HG, Mrvichin N, Kaats GR, Bagchi D, Clouatre D. Reflecting on concepts relevant to contemplating the relationships between glucose-insulin perturbations, nutrition, and aging . J Am Coll Nutr. 2019;38(5):463–9. doi:10.1080/07315724.2018.1529640.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Kaats GR. Examining possible causes for age-related blood pressure elevation in 107 females volunteering for a weight loss study. Original Internist. 2011;18:92–5.
   Google Scholar
• Nugent SD, Kaats GR, Preuss HG. Discordance between body mass index (BMI) and novel body composition change index (BCCI) as outcome measures in weight change intervention. J Amer Coll Nutr. 2018;37:336–41.
   PubMed Web of Science ®Google Scholar
• Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM. Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes. 1974;23(8):674–8. doi:10.2337/diab.23.8.674.
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease). Diabetes. 1988;37(12):1595–607. doi:10.2337/diab.37.12.1595.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–94. doi:10.2337/diacare.14.3.173.
   PubMed Web of Science ®Google Scholar
• Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J. 1922;12(3):141–6.
   PubMedGoogle Scholar
• Himsworth H. Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;1:127–30.
   Google Scholar
• Bricker NS. On the pathogenesis of the uremic state. An exposition of off hypothesis"” trade-off. N Engl J Med. 1972;286(20):1093–9. doi:10.1056/NEJM197205182862009.
   PubMed Web of Science ®Google Scholar
• Preuss HG. The insulin system in health and disease (Editorial). J Am Coll Nutr. 1997;16(5):393–4. doi:10.1080/07315724.1997.10718702.
   PubMed Web of Science ®Google Scholar
• Preuss HG. Effects of glucose/insulin perturbations on aging and chronic disorders of aging: the evidence. J Am Coll Nutr. 1997;16(5):397–403. doi:10.1080/07315724.1997.10718704.
   PubMed Web of Science ®Google Scholar
• Preuss HG. The bitter sweet. North Charleston, South Carolina: Marcell Publishing. p. 1–116. 2017.
   Google Scholar
• Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin resistant state. J Cardiovac Pharmacol. 1990;15(Suppl 3):S18–S25. doi:10.1097/00005344-199000005-00004.
   PubMedGoogle Scholar
• Mitri J, Muraru MD, Pittas AG. Pittas AG: Vitamin D3 and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65(9):1005–15. doi:10.1038/ejcn.2011.118.
   PubMed Web of Science ®Google Scholar
• Mark KA, Dumas KJ, Bhaumik D, Schilling B, Davis S, Oron TR, Sorensen DJ, Lucanic M, Brem RB, Melov S, et al. Vitamin D promotes protein homeostasis and longevity via the stress response pathway genes skn-1, ire-1, and xbp-1. Cell Rep. 2016;17(5):1227–37., : doi:10.1016/j.celrep.2016.09.086.
   PubMed Web of Science ®Google Scholar
• Noordam R, de Craen AJ, Pedram P Pedram P, Maier AB, Mooijaart SP, van Pelt J, Feskens EJ, Streppel MT, Slagboom PE, Westendorp RG, et al. Levels of 25-hyroxyvitamin D3 in familial longevity: the Leiden Longevity Study. Canadian Medical Asssoc J. 2012;184(18):E963–E968.: doi:10.1503/cmaj.120233.
   PubMed Web of Science ®Google Scholar
• Preuss HG, Echard B, Clouatre D, Bagchi D, Perricone NV. Niacin-bound chromium increases life span in Zucker Fatty Rats. J Inorg Biochem. 2011;105(10):1344–9. doi:10.1016/j.jinorgbio.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Angellotti E, Pittas AG. The role of vitamin D in the prevention of type 2 diabetes: to D or not to D?. Endocrinology. 2017;158(7):2013–21. doi:10.1210/en.2017-00265.
   PubMed Web of Science ®Google Scholar
• Imanparast F, Javaheri J, Kamankesh F, Rafiei F, Salehi A, Mollaaliakbari Z, Rezaei F, Rahimi A, Abbasi E. The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo controlled trial. Appl Physiol Nutr Metab. 2020;45(5):471–7. doi:10.1139/apnm-2019-0113.
   Web of Science ®Google Scholar
• Wimalawansa SJ. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol. 2018;175:177–89. doi:10.1016/j.jsbmb.2016.09.017.
   PubMed Web of Science ®Google Scholar
• Wimalawansa SJ. Causes, benefits and consequences of vitamin D deficiency. Int J Endocrinol Diabetes. 2019;2(1):108.
   Google Scholar